Mycapssa is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Amryt Pharmaceuticals Designated Activity Company. The primary component is Octreotide.
Product ID | 69880-120_55f04a73-a366-4c65-9ed5-c3051668fa19 |
NDC | 69880-120 |
Product Type | Human Prescription Drug |
Proprietary Name | Mycapssa |
Generic Name | Octreotide |
Dosage Form | Capsule, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2020-07-06 |
Marketing Category | NDA / NDA |
Application Number | NDA208232 |
Labeler Name | Amryt Pharmaceuticals Designated Activity Company |
Substance Name | OCTREOTIDE |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-07-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MYCAPSSA 86041709 4998596 Live/Registered |
GENENTECH, INC. 2013-08-19 |